StockData
NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd. (NRSN) stock

NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.51−0.05 (-3.51%)

Close on Nov 17, 2026Market cap $2.77MP/E –Yield –

NeuroSense Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$8.80. The highest annual figure on record is -$8.80 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.80–
FY2024Dec 31, 2024-$10.80–
FY2023Dec 31, 2023-$14.80–
FY2022Dec 31, 2022-$18.20–
FY2021Dec 31, 2021-$10.40–
FY2020Dec 31, 2020-$10.20–

More NeuroSense Therapeutics figures

See a number that looks wrong?